Free Trial
OTCMKTS:GSTC

GlobeStar Therapeutics (GSTC) Stock Price, News & Analysis

About GlobeStar Therapeutics Stock (OTCMKTS:GSTC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
8,020 shs
Average Volume
8,020 shs
Market Capitalization
$120 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

Receive GSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GSTC Stock News Headlines

"I'm risking my reputation on this"
What the headlines won't tell you: Smart money was positioned before both events. They didn't react to news—they anticipated it. How? They follow patterns. Market cycles. Institutional flows. The same patterns we document in Crypto Revolution and the next pattern is forming now.
KHTRF Knight Therapeutics Inc.
GlobeStar Therapeutics Corp GSTC
See More Headlines

GSTC Stock Analysis - Frequently Asked Questions

Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that GlobeStar Therapeutics investors own include Arrival (ARVL), Cosmos Health (COSM), COMSovereign (COMS), Good Hemp (GHMP), Meta Materials (MMTLP), Palisade Bio (PALI) and Sintx Technologies (SINT).

Company Calendar

Today
6/28/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:GSTC
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,241,110,000
Free Float
1,210,078,000
Market Cap
$120 thousand
Optionable
Not Optionable
Beta
2.55
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (OTCMKTS:GSTC) was last updated on 6/28/2025 by MarketBeat.com Staff
From Our Partners